(Total Views: 405)
Posted On: 10/08/2020 4:18:08 PM
Post# of 36567
Is Sinopharm the Chinese company that NGIO signed the LOI with?
PR - Aug 25 2020
"Letter of Intent (LOI) signed with potential partners in China to develop the Ii-Key-SARS-CoV-2 vaccine for China with a proposed $5 million upfront payment upon contract signing and minimum of $400 million if the vaccine is proven successful in clinical trials."
PR - Aug 25 2020
"Letter of Intent (LOI) signed with potential partners in China to develop the Ii-Key-SARS-CoV-2 vaccine for China with a proposed $5 million upfront payment upon contract signing and minimum of $400 million if the vaccine is proven successful in clinical trials."
(1)
(0)
